Hans Lennart Rudolf Wigzell - 08 Mar 2024 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role: Director
Signature: /s/ Ryan Brown, as Attorney-in-Fact for Hans Wigzell
Issuer symbol: SRPT
Transactions as of: 08 Mar 2024
Net transactions value: -$1,640,295
Form type: 4
Filing time: 11 Mar 2024, 20:02:32 UTC
Previous filing: 05 Mar 2024
Next filing: 16 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRPT	Common Stock	Options Exercise	$208,500	+15,000	+66%	$13.90	37,840	08 Mar 2024	Direct
transaction	SRPT	Common Stock	Sale	$390,747	-3,155	-8.3%	$123.85	34,685	08 Mar 2024	Direct	F1
transaction	SRPT	Common Stock	Sale	$1,445,810	-11,745	-34%	$123.10	22,940	08 Mar 2024	Direct	F2
transaction	SRPT	Common Stock	Sale	$12,239	-100	-0.44%	$122.39	22,840	08 Mar 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SRPT	Stock Option (right to buy)	Options Exercise	$0	-15,000	-100%	$0.000000^*	0	08 Mar 2024	Common Stock	15,000	$13.90	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $123.6 to $124.6, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F2	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $122.65 to $123.58, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $123.6 to $124.6, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $122.65 to $123.58, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.